Biosig Technologies EBITDA 2012-2024 | BSGM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Biosig Technologies ebitda from 2012 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Biosig Technologies ebitda from 2012 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$228.7B
Intuitive Surgical (ISRG)	$171.3B
Alcon (ALC)	$48B
IQVIA Holdings (IQV)	$41.9B
Edwards Lifesciences (EW)	$39.5B
IDEXX Laboratories (IDXX)	$39.3B
DexCom (DXCM)	$27.3B
STERIS (STE)	$22.8B
SONOVA HOLDING (SONVY)	$21.9B
Waters (WAT)	$20.9B
Hologic (HOLX)	$18.6B
Sysmex ADR (SSMXY)	$12.5B
Fresenius Medical Care AG KGaA (FMS)	$12.1B
Teleflex (TFX)	$11.3B
Globus Medical (GMED)	$9.6B
Penumbra (PEN)	$7.6B
Masimo (MASI)	$7.4B
Glaukos (GKOS)	$7.2B
TransMedics (TMDX)	$4.6B
Integer Holdings (ITGR)	$4.3B
PROCEPT BioRobotics (PRCT)	$3.8B
LivaNova (LIVN)	$2.9B
Tandem Diabetes Care (TNDM)	$2.7B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.6B
Veracyte (VCYT)	$2.5B
Inari Medical (NARI)	$2.4B
RxSight (RXST)	$1.8B
Integra LifeSciences Holdings (IART)	$1.3B
Artivion (AORT)	$1.1B